These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 8235612

  • 1. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
    Ebner R, Chen RH, Lawler S, Zioncheck T, Derynck R.
    Science; 1993 Nov 05; 262(5135):900-2. PubMed ID: 8235612
    [Abstract] [Full Text] [Related]

  • 2. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.
    Attisano L, Cárcamo J, Ventura F, Weis FM, Massagué J, Wrana JL.
    Cell; 1993 Nov 19; 75(4):671-80. PubMed ID: 8242742
    [Abstract] [Full Text] [Related]

  • 3. Characterization of type I receptors for transforming growth factor-beta and activin.
    ten Dijke P, Yamashita H, Ichijo H, Franzén P, Laiho M, Miyazono K, Heldin CH.
    Science; 1994 Apr 01; 264(5155):101-4. PubMed ID: 8140412
    [Abstract] [Full Text] [Related]

  • 4. The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling.
    Wang T, Danielson PD, Li BY, Shah PC, Kim SD, Donahoe PK.
    Science; 1996 Feb 23; 271(5252):1120-2. PubMed ID: 8599089
    [Abstract] [Full Text] [Related]

  • 5. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
    Cárcamo J, Weis FM, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J.
    Mol Cell Biol; 1994 Jun 23; 14(6):3810-21. PubMed ID: 8196624
    [Abstract] [Full Text] [Related]

  • 6. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
    Takumi T, Moustakas A, Lin HY, Lodish HF.
    Exp Cell Res; 1995 Jan 23; 216(1):208-14. PubMed ID: 7813622
    [Abstract] [Full Text] [Related]

  • 7. Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.
    Lux A, Attisano L, Marchuk DA.
    J Biol Chem; 1999 Apr 09; 274(15):9984-92. PubMed ID: 10187774
    [Abstract] [Full Text] [Related]

  • 8. Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors.
    De Winter JP, De Vries CJ, Van Achterberg TA, Ameerun RF, Feijen A, Sugino H, De Waele P, Huylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ.
    Exp Cell Res; 1996 May 01; 224(2):323-34. PubMed ID: 8612709
    [Abstract] [Full Text] [Related]

  • 9. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor.
    Matsuzaki K, Xu J, Wang F, McKeehan WL, Krummen L, Kan M.
    J Biol Chem; 1993 Jun 15; 268(17):12719-23. PubMed ID: 8389764
    [Abstract] [Full Text] [Related]

  • 10. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
    Franzén A, Piek E, Westermark B, ten Dijke P, Heldin NE.
    Endocrinology; 1999 Sep 15; 140(9):4300-10. PubMed ID: 10465304
    [Abstract] [Full Text] [Related]

  • 11. Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor.
    Ebner R, Chen RH, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R.
    Science; 1993 May 28; 260(5112):1344-8. PubMed ID: 8388127
    [Abstract] [Full Text] [Related]

  • 12. GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor beta and activin-A.
    Moustakas A, Takumi T, Lin HY, Lodish HF.
    J Biol Chem; 1995 Jan 13; 270(2):765-9. PubMed ID: 7822308
    [Abstract] [Full Text] [Related]

  • 13. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
    Alexander JM, Bikkal HA, Zervas NT, Laws ER, Klibanski A.
    J Clin Endocrinol Metab; 1996 Feb 13; 81(2):783-90. PubMed ID: 8636304
    [Abstract] [Full Text] [Related]

  • 14. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.
    Xu J, McKeehan K, Matsuzaki K, McKeehan WL.
    J Biol Chem; 1995 Mar 17; 270(11):6308-13. PubMed ID: 7890768
    [Abstract] [Full Text] [Related]

  • 15. The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesoderm.
    Bhushan A, Lin HY, Lodish HF, Kintner CR.
    Mol Cell Biol; 1994 Jun 17; 14(6):4280-5. PubMed ID: 8196664
    [Abstract] [Full Text] [Related]

  • 16. Structural and functional evidence for a singular repertoire of BMP receptor signal transducing proteins in the lophotrochozoan Crassostrea gigas suggests a shared ancestral BMP/activin pathway.
    Herpin A, Lelong C, Becker T, Rosa F, Favrel P, Cunningham C.
    FEBS J; 2005 Jul 17; 272(13):3424-40. PubMed ID: 15978047
    [Abstract] [Full Text] [Related]

  • 17. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors.
    Rodriguez C, Chen F, Weinberg RA, Lodish HF.
    J Biol Chem; 1995 Jul 07; 270(27):15919-22. PubMed ID: 7608141
    [Abstract] [Full Text] [Related]

  • 18. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
    Feng XH, Derynck R.
    EMBO J; 1997 Jul 01; 16(13):3912-23. PubMed ID: 9233801
    [Abstract] [Full Text] [Related]

  • 19. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
    Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W.
    Nature; 2000 Mar 23; 404(6776):411-4. PubMed ID: 10746731
    [Abstract] [Full Text] [Related]

  • 20. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.
    Barbara NP, Wrana JL, Letarte M.
    J Biol Chem; 1999 Jan 08; 274(2):584-94. PubMed ID: 9872992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.